The top iPhone model Apple Watch available at the moment includes the iPhone 15

Four things to be aware of regarding The top iPhone model Apple Watch available at the moment includes the iPhone 15 debacle

Finding the newest Apple Watch models in the US will get much more difficult in the near future.

In an effort to avoid potentially becoming embroiled in one of the biggest patent challenges in recent memory, Apple announced on Monday that it will cease selling some models of its best-selling wristwatch starting later this week.

The decision to take an exceptionally well-liked product off shop shelves was prompted by an International Trade Commission decision that found Apple to be infringing on the patent of the medical company Masimo’s pulse oximeter. That device measures blood oxygen levels by use of light. In 2020, Apple Watch Series 6 added a pulse oximeter feature that made use of the technique.

Now that the decision has been vetoed by President Joe Biden during a review period, Apple may have to face the prospect of having these models outlawed unless the company makes significant modifications to the way the Apple Watch functions. Apple stated that it is “preemptively taking steps to comply should the ruling stand” by eliminating some, even though the review process doesn’t finish until December 25.

Here’s a deeper look at all the information you require:

Which models won’t be available?

Apple informed CNN that, as of Thursday, it will no longer be selling the Apple Watch Series 9 and Apple Watch Ultra 2 in the US online or at physical stores after December 24.

While some models will still be on sale, others would become more difficult to find if an import restriction is passed. This would cover all Apple Watch Ultra models as well as those released after Series 6. Apple claims that a ban won’t affect sales of the Apple Watch SE. Best Buy, among other shops, informed CNN that it still intends to sell the gadgets.

Apple stated that it will “continue to take all measures” to make the order available for users “as soon as possible” if it remains in place.

Why is Apple acting in this way?
Apple’s decision to remove one of its best-selling items from the market comes after a prolonged legal battle with Masimo regarding the product’s blood oxygen functionality. Apple has consistently promoted its smartwatch as a life-saving tool, making it the most widely used watch on the market worldwide. However, this strategy may be jeopardized by its spat with Masimo.

After the ITC discovered that multiple Apple Watches violated Masimo’s pulse oximeter patents over two months ago, a review period was instituted, during which Apple may either reach a licensing agreement with Masimo or file an appeal to override the ban.

According to Masimo CEO Joe Kiani, he is open to both a license arrangement and a settlement, but Apple has not contacted the company about either.

Apple, meanwhile, declared its unwavering belief that the ITC’s conclusions are false and ought to be overturned. Additionally, it intends to appeal the ruling to the Federal Circuit. Furthermore, Apple claimed to have presented data showing how a ban would have a detrimental effect on scientific and medical research, healthcare, and Apple Watch users who depend on the ECG, blood oxygen level, and other health-related functions. People with heart failure, lung cancer, asthma, and other medical disorders can benefit greatly from pulse oximeters.

According to Kiani, the decision to stop selling the gadgets is just the most recent blow in the continuing patent battle. Additionally, Masimo has claimed in court that prior to the release of Apple’s W1 medical wristwatch in May 2022, the company stole the work of over twenty-two of its employees.